Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04971993 · ClinicalTrials.gov registry record
Step and Walking Pattern From Cardiac Monitor Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- 40
- Enrollment target
NCT04971993: Clinical Trial study, sponsored by Boston Scientific Corporation.
NCT04971993 is a clinical trial that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04971993 was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
To understand the feasibility of characterizing walking patterns in heart failure subjects and subjects at risk for arrhythmias using an investigational wearable monitor called the SWAN study system.
Primary Outcome
Characterize step count in class II and III heart failure and in ICM indicated patients with no history of heart failure.
Interventions
- DEVICE Wearable Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-01-05 |
| Est. Completion | 2023-10-11 |
Why NCT04971993 stopped before completion
NCT04971993 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Wearable Cardiac Monitor is the first listed.
NCT04971993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04971993 about?
NCT04971993 is a clinical study titled "Step and Walking Pattern From Cardiac Monitor Study". To understand the feasibility of characterizing walking patterns in heart failure subjects and subjects at risk for arrhythmias using an investigational wearable monitor called the SWAN study system.
What is the current status of trial NCT04971993?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2022-01-05. Estimated completion is 2023-10-11.
What interventions are being tested in trial NCT04971993?
The interventions under investigation include: Wearable Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT04971993?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI